nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Doxorubicin—testicular cancer	0.184	0.231	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—testicular cancer	0.069	0.0868	CbGbCtD
Carbamazepine—CYP3A7—Ifosfamide—testicular cancer	0.0395	0.0497	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0395	0.0497	CbGbCtD
Carbamazepine—CYP2B6—Ifosfamide—testicular cancer	0.0376	0.0473	CbGbCtD
Carbamazepine—ABCC2—Carboplatin—testicular cancer	0.0337	0.0424	CbGbCtD
Carbamazepine—ABCC2—Vinblastine—testicular cancer	0.0314	0.0395	CbGbCtD
Carbamazepine—CYP3A5—Ifosfamide—testicular cancer	0.0296	0.0373	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—testicular cancer	0.0288	0.0362	CbGbCtD
Carbamazepine—CYP2C8—Ifosfamide—testicular cancer	0.0285	0.0359	CbGbCtD
Carbamazepine—ABCC2—Etoposide—testicular cancer	0.0283	0.0356	CbGbCtD
Carbamazepine—CYP2C19—Ifosfamide—testicular cancer	0.0239	0.0301	CbGbCtD
Carbamazepine—CYP2C9—Ifosfamide—testicular cancer	0.0199	0.025	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—testicular cancer	0.0193	0.0243	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—testicular cancer	0.0187	0.0235	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—testicular cancer	0.0183	0.023	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—testicular cancer	0.0163	0.0206	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—testicular cancer	0.0142	0.0178	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—testicular cancer	0.0136	0.0171	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—testicular cancer	0.0123	0.0154	CbGbCtD
Carbamazepine—CYP3A4—Ifosfamide—testicular cancer	0.0115	0.0145	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—testicular cancer	0.0105	0.0133	CbGbCtD
Carbamazepine—ABCB1—Vinblastine—testicular cancer	0.0102	0.0129	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—testicular cancer	0.00966	0.0122	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—testicular cancer	0.00938	0.0118	CbGbCtD
Carbamazepine—ABCB1—Etoposide—testicular cancer	0.00921	0.0116	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—testicular cancer	0.00628	0.00791	CbGbCtD
Carbamazepine—CYP3A4—Vinblastine—testicular cancer	0.00613	0.00771	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—testicular cancer	0.00609	0.00766	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—testicular cancer	0.00552	0.00695	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—testicular cancer	0.00376	0.00474	CbGbCtD
Carbamazepine—Hypersensitivity—Cisplatin—testicular cancer	0.000106	0.000516	CcSEcCtD
Carbamazepine—Bradycardia—Epirubicin—testicular cancer	0.000106	0.000515	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—testicular cancer	0.000105	0.000513	CcSEcCtD
Carbamazepine—Rash—Ifosfamide—testicular cancer	0.000105	0.000512	CcSEcCtD
Carbamazepine—Dermatitis—Ifosfamide—testicular cancer	0.000105	0.000512	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—testicular cancer	0.000105	0.000511	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000105	0.000511	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—testicular cancer	0.000105	0.00051	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—testicular cancer	0.000105	0.000508	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—testicular cancer	0.000105	0.000508	CcSEcCtD
Carbamazepine—Rhinitis—Epirubicin—testicular cancer	0.000104	0.000507	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—testicular cancer	0.000104	0.000507	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—testicular cancer	0.000104	0.000507	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—testicular cancer	0.000104	0.000507	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—testicular cancer	0.000104	0.000507	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—testicular cancer	0.000104	0.000506	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—testicular cancer	0.000104	0.000505	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—testicular cancer	0.000104	0.000504	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—testicular cancer	0.000103	0.000502	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—testicular cancer	0.000103	0.000502	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—testicular cancer	0.000103	0.000502	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—testicular cancer	0.000103	0.0005	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—testicular cancer	0.000103	0.000499	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—testicular cancer	0.000102	0.000497	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—testicular cancer	0.000102	0.000497	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—testicular cancer	0.000102	0.000496	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000101	0.000493	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—testicular cancer	0.000101	0.000491	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—testicular cancer	0.000101	0.000489	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—testicular cancer	0.0001	0.000488	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—testicular cancer	0.0001	0.000487	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—testicular cancer	0.0001	0.000487	CcSEcCtD
Carbamazepine—Chills—Methotrexate—testicular cancer	9.98e-05	0.000485	CcSEcCtD
Carbamazepine—Nausea—Ifosfamide—testicular cancer	9.92e-05	0.000482	CcSEcCtD
Carbamazepine—Diarrhoea—Cisplatin—testicular cancer	9.86e-05	0.000479	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—testicular cancer	9.84e-05	0.000478	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—testicular cancer	9.83e-05	0.000478	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—testicular cancer	9.81e-05	0.000477	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—testicular cancer	9.75e-05	0.000474	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—testicular cancer	9.73e-05	0.000473	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—testicular cancer	9.72e-05	0.000473	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—testicular cancer	9.71e-05	0.000472	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—testicular cancer	9.68e-05	0.000471	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—testicular cancer	9.68e-05	0.000471	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—testicular cancer	9.66e-05	0.00047	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—testicular cancer	9.66e-05	0.00047	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—testicular cancer	9.66e-05	0.000469	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—testicular cancer	9.63e-05	0.000468	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—testicular cancer	9.56e-05	0.000465	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—testicular cancer	9.51e-05	0.000462	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—testicular cancer	9.49e-05	0.000461	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—testicular cancer	9.48e-05	0.000461	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—testicular cancer	9.47e-05	0.00046	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—testicular cancer	9.47e-05	0.00046	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—testicular cancer	9.45e-05	0.000459	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—testicular cancer	9.44e-05	0.000459	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—testicular cancer	9.4e-05	0.000457	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—testicular cancer	9.38e-05	0.000456	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—testicular cancer	9.37e-05	0.000455	CcSEcCtD
Carbamazepine—Chills—Epirubicin—testicular cancer	9.34e-05	0.000454	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—testicular cancer	9.34e-05	0.000454	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—testicular cancer	9.3e-05	0.000452	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—testicular cancer	9.2e-05	0.000447	CcSEcCtD
Carbamazepine—Vomiting—Cisplatin—testicular cancer	9.16e-05	0.000445	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—testicular cancer	9.13e-05	0.000444	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—testicular cancer	9.12e-05	0.000443	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—testicular cancer	9.11e-05	0.000443	CcSEcCtD
Carbamazepine—Rash—Cisplatin—testicular cancer	9.08e-05	0.000441	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—testicular cancer	9.07e-05	0.000441	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—testicular cancer	9.06e-05	0.000441	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—testicular cancer	9.06e-05	0.000441	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—testicular cancer	9.03e-05	0.000439	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—testicular cancer	9e-05	0.000438	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—testicular cancer	8.98e-05	0.000437	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—testicular cancer	8.95e-05	0.000435	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—testicular cancer	8.94e-05	0.000435	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—testicular cancer	8.94e-05	0.000435	CcSEcCtD
Carbamazepine—Tension—Epirubicin—testicular cancer	8.89e-05	0.000432	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—testicular cancer	8.88e-05	0.000431	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—testicular cancer	8.8e-05	0.000428	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—testicular cancer	8.77e-05	0.000426	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—testicular cancer	8.74e-05	0.000425	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—testicular cancer	8.73e-05	0.000424	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—testicular cancer	8.71e-05	0.000424	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—testicular cancer	8.7e-05	0.000423	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—testicular cancer	8.7e-05	0.000423	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—testicular cancer	8.68e-05	0.000422	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—testicular cancer	8.67e-05	0.000421	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—testicular cancer	8.64e-05	0.00042	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—testicular cancer	8.61e-05	0.000418	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—testicular cancer	8.56e-05	0.000416	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—testicular cancer	8.54e-05	0.000415	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—testicular cancer	8.51e-05	0.000414	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—testicular cancer	8.44e-05	0.00041	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—testicular cancer	8.39e-05	0.000408	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—testicular cancer	8.39e-05	0.000408	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—testicular cancer	8.39e-05	0.000408	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—testicular cancer	8.39e-05	0.000408	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—testicular cancer	8.38e-05	0.000407	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—testicular cancer	8.33e-05	0.000405	CcSEcCtD
Carbamazepine—Rash—Etoposide—testicular cancer	8.32e-05	0.000404	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—testicular cancer	8.31e-05	0.000404	CcSEcCtD
Carbamazepine—Headache—Etoposide—testicular cancer	8.27e-05	0.000402	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—testicular cancer	8.25e-05	0.000401	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—testicular cancer	8.25e-05	0.000401	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—testicular cancer	8.25e-05	0.000401	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—testicular cancer	8.23e-05	0.0004	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—testicular cancer	8.21e-05	0.000399	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	8.19e-05	0.000398	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—testicular cancer	8.15e-05	0.000396	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—testicular cancer	8.14e-05	0.000396	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—testicular cancer	8.13e-05	0.000395	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—testicular cancer	8.11e-05	0.000394	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—testicular cancer	8.11e-05	0.000394	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—testicular cancer	8.06e-05	0.000392	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—testicular cancer	7.97e-05	0.000387	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—testicular cancer	7.97e-05	0.000387	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—testicular cancer	7.9e-05	0.000384	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—testicular cancer	7.9e-05	0.000384	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—testicular cancer	7.85e-05	0.000382	CcSEcCtD
Carbamazepine—Infection—Methotrexate—testicular cancer	7.85e-05	0.000382	CcSEcCtD
Carbamazepine—Nausea—Etoposide—testicular cancer	7.84e-05	0.000381	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—testicular cancer	7.83e-05	0.00038	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—testicular cancer	7.75e-05	0.000377	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—testicular cancer	7.75e-05	0.000377	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—testicular cancer	7.74e-05	0.000376	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—testicular cancer	7.72e-05	0.000375	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—testicular cancer	7.72e-05	0.000375	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—testicular cancer	7.72e-05	0.000375	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—testicular cancer	7.71e-05	0.000375	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—testicular cancer	7.69e-05	0.000374	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—testicular cancer	7.68e-05	0.000373	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	7.66e-05	0.000372	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—testicular cancer	7.64e-05	0.000371	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—testicular cancer	7.55e-05	0.000367	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—testicular cancer	7.53e-05	0.000366	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—testicular cancer	7.53e-05	0.000366	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—testicular cancer	7.52e-05	0.000366	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—testicular cancer	7.51e-05	0.000365	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—testicular cancer	7.46e-05	0.000363	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—testicular cancer	7.4e-05	0.00036	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—testicular cancer	7.4e-05	0.00036	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—testicular cancer	7.39e-05	0.000359	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—testicular cancer	7.37e-05	0.000358	CcSEcCtD
Carbamazepine—Infection—Epirubicin—testicular cancer	7.35e-05	0.000357	CcSEcCtD
Carbamazepine—Shock—Epirubicin—testicular cancer	7.28e-05	0.000354	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—testicular cancer	7.27e-05	0.000353	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—testicular cancer	7.25e-05	0.000353	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—testicular cancer	7.24e-05	0.000352	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—testicular cancer	7.24e-05	0.000352	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—testicular cancer	7.22e-05	0.000351	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.2e-05	0.00035	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—testicular cancer	7.18e-05	0.000349	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—testicular cancer	7.15e-05	0.000348	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—testicular cancer	7.15e-05	0.000347	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—testicular cancer	7.14e-05	0.000347	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—testicular cancer	7.14e-05	0.000347	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—testicular cancer	7.14e-05	0.000347	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—testicular cancer	7.11e-05	0.000346	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—testicular cancer	7.1e-05	0.000345	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	7.09e-05	0.000345	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—testicular cancer	7.05e-05	0.000343	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—testicular cancer	7.05e-05	0.000343	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—testicular cancer	7.03e-05	0.000342	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—testicular cancer	6.98e-05	0.000339	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—testicular cancer	6.96e-05	0.000338	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—testicular cancer	6.91e-05	0.000336	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—testicular cancer	6.9e-05	0.000335	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—testicular cancer	6.87e-05	0.000334	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—testicular cancer	6.84e-05	0.000333	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—testicular cancer	6.84e-05	0.000333	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—testicular cancer	6.82e-05	0.000332	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—testicular cancer	6.81e-05	0.000331	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—testicular cancer	6.8e-05	0.00033	CcSEcCtD
Carbamazepine—Pain—Methotrexate—testicular cancer	6.76e-05	0.000329	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.74e-05	0.000328	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—testicular cancer	6.73e-05	0.000327	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—testicular cancer	6.71e-05	0.000326	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—testicular cancer	6.7e-05	0.000326	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—testicular cancer	6.69e-05	0.000325	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—testicular cancer	6.68e-05	0.000325	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—testicular cancer	6.65e-05	0.000323	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—testicular cancer	6.64e-05	0.000323	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—testicular cancer	6.62e-05	0.000322	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—testicular cancer	6.59e-05	0.000321	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—testicular cancer	6.58e-05	0.00032	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—testicular cancer	6.52e-05	0.000317	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—testicular cancer	6.51e-05	0.000317	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—testicular cancer	6.51e-05	0.000316	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—testicular cancer	6.46e-05	0.000314	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—testicular cancer	6.43e-05	0.000313	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—testicular cancer	6.4e-05	0.000311	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—testicular cancer	6.39e-05	0.00031	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—testicular cancer	6.38e-05	0.00031	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—testicular cancer	6.33e-05	0.000307	CcSEcCtD
Carbamazepine—Pain—Epirubicin—testicular cancer	6.33e-05	0.000307	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—testicular cancer	6.28e-05	0.000305	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—testicular cancer	6.25e-05	0.000304	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—testicular cancer	6.25e-05	0.000304	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.24e-05	0.000303	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—testicular cancer	6.19e-05	0.000301	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—testicular cancer	6.15e-05	0.000299	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—testicular cancer	6.1e-05	0.000297	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—testicular cancer	6.1e-05	0.000296	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—testicular cancer	6.08e-05	0.000296	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—testicular cancer	6.05e-05	0.000294	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—testicular cancer	6.02e-05	0.000293	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—testicular cancer	5.95e-05	0.000289	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.91e-05	0.000287	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—testicular cancer	5.9e-05	0.000287	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—testicular cancer	5.88e-05	0.000286	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—testicular cancer	5.85e-05	0.000284	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—testicular cancer	5.85e-05	0.000284	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—testicular cancer	5.85e-05	0.000284	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—testicular cancer	5.85e-05	0.000284	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—testicular cancer	5.82e-05	0.000283	CcSEcCtD
Carbamazepine—Asthenia—Methotrexate—testicular cancer	5.67e-05	0.000276	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—testicular cancer	5.64e-05	0.000274	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—testicular cancer	5.6e-05	0.000272	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—testicular cancer	5.59e-05	0.000272	CcSEcCtD
Carbamazepine—Hypersensitivity—Epirubicin—testicular cancer	5.45e-05	0.000265	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—testicular cancer	5.44e-05	0.000264	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—testicular cancer	5.41e-05	0.000263	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—testicular cancer	5.41e-05	0.000263	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—testicular cancer	5.41e-05	0.000263	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—testicular cancer	5.31e-05	0.000258	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—testicular cancer	5.23e-05	0.000254	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—testicular cancer	5.23e-05	0.000254	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—testicular cancer	5.06e-05	0.000246	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—testicular cancer	5.04e-05	0.000245	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—testicular cancer	5.03e-05	0.000244	CcSEcCtD
Carbamazepine—Rash—Methotrexate—testicular cancer	4.98e-05	0.000242	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—testicular cancer	4.98e-05	0.000242	CcSEcCtD
Carbamazepine—Headache—Methotrexate—testicular cancer	4.95e-05	0.000241	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—testicular cancer	4.91e-05	0.000239	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—testicular cancer	4.89e-05	0.000238	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—testicular cancer	4.84e-05	0.000235	CcSEcCtD
Carbamazepine—Vomiting—Epirubicin—testicular cancer	4.7e-05	0.000229	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—testicular cancer	4.69e-05	0.000228	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—testicular cancer	4.68e-05	0.000228	CcSEcCtD
Carbamazepine—Rash—Epirubicin—testicular cancer	4.66e-05	0.000227	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—testicular cancer	4.66e-05	0.000226	CcSEcCtD
Carbamazepine—Headache—Epirubicin—testicular cancer	4.63e-05	0.000225	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—testicular cancer	4.53e-05	0.00022	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—testicular cancer	4.39e-05	0.000214	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—testicular cancer	4.35e-05	0.000212	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—testicular cancer	4.32e-05	0.00021	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—testicular cancer	4.31e-05	0.00021	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—testicular cancer	4.29e-05	0.000208	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—testicular cancer	4.07e-05	0.000198	CcSEcCtD
